Cited 0 times in
JIN-A02, a fourth-generation, highly effective tyrosine kinase inhibitor with intracranial activity, targeting EGFR C797S mutations in NSCLC
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.